UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia

Journal of clinical oncology, 2008-01, Vol.26 (1), p.76-82

2008

Volltextzugriff (PDF)

Combination of Molecular Alterations and Smoking Intensity Predicts Bladder Cancer Outcome: A Report From the Los Angeles Cancer Surveillance Program

Cancer, 2013-02, Vol.119 (4), p.756-765

2013

Volltextzugriff (PDF)

HER2 Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical Trials

Journal of clinical oncology, 2016-10, Vol.34 (29), p.3518-3528

2016

Volltextzugriff (PDF)

Phase II California Cancer Consortium Trial of Gemcitabine-Eribulin Combination in Cisplatin-Ineligible Patients With Metastatic Urothelial Carcinoma: Final Report (NCI-9653)

Journal of clinical oncology, 2019-10, Vol.37 (29), p.2682-2688

2019

Volltextzugriff (PDF)

Temozolomide for treatment-resistant recurrent meningioma

Neurology, 2004-04, Vol.62 (7), p.1210-1212

2004

Volltextzugriff (PDF)

Early ductal decompression versus conservative management for gallstone pancreatitis with ampullary obstruction : A prospective randomized clinical trial

Annals of surgery, 2006, Vol.243 (1), p.33-40

2006

Volltextzugriff (PDF)

Carditis: a manifestation of gastroesophageal reflux disease

The American journal of surgical pathology, 2001-02, Vol.25 (2), p.245-252

2001

Volltextzugriff (PDF)

560 COMBINATION OF MOLECULAR ALTERATIONS AND SMOKING INTENSITY PREDICTS BLADDER CANCER OUTCOME: A REPORT FROM THE LOS ANGELES CANCER SURVEILLANCE PROGRAM

The Journal of urology, 2012-04, Vol.187 (4), p.e229-e229

2012

Volltextzugriff (PDF)

Phase I clinical trial of pegylated liposomal Doxorubicin and docetaxel in patients with advanced solid tumors

American journal of clinical oncology, 2011-02, Vol.34 (1), p.27-31

2011

Volltextzugriff (PDF)

Telomerase and markers of cellular proliferation are associated with the progression of cervical intraepithelial neoplasia lesions

International journal of gynecological pathology, 2007-07, Vol.26 (3), p.214-222

2007

Volltextzugriff (PDF)

EphrinB2 (B2) expression predicts poor response to PD1/L1 antibodies (Ab) in metastatic urothelial carcinoma (mUC)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.4575-4575

2023

Volltextzugriff (PDF)

A phase 1 dose escalation/expansion study of FID-007, a novel nanoparticle paclitaxel formulation, in patients with solid tumors

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.3026-3026

2023

Volltextzugriff (PDF)

Changes in ctDNA levels after MIBG therapy in patients with relapsed or refractory neuroblastoma

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.10012-10012

2021

Volltextzugriff (PDF)

Phase II randomized double blind trial of axitinib (Axi) +/- PF-04518600, an OX40 antibody (PFOX) after PD1/PDL1 antibody (IO) therapy (Tx) in metastatic renal cell carcinoma (mRCC)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4529-4529

2022

Volltextzugriff (PDF)

Neoplastic meningitis-related encephalopathy: prognostic significance

Neurology, 2004-12, Vol.63 (11), p.2159-2161

2004

Volltextzugriff (PDF)

Group psychotherapy for women molested in childhood : Psychological and somatic symptoms and medical visits

International journal of group psychotherapy, 1998-10, Vol.48 (4), p.533-541

1998

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(11)

Publikationsform

Artikel
(16)

Sprache

Englisch
(16)

Erscheinungsjahr

n.n

Thema

Humans
(11)
Female
(10)
Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Aged
(8)
Biological And Medical Sciences
(8)
Medical Sciences
(8)
Middle Aged
(8)
Treatment Outcome
(7)
Adult
(6)
Male
(6)
Oncology
(5)
Aged, 80 And Over
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)
Survival Rate
(4)
Disease Progression
(3)
Immunohistochemistry
(3)
Prognosis
(3)
Retrospective Studies
(3)
Tumors
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia

Combination of Molecular Alterations and Smoking Intensity Predicts Bladder Cancer Outcome: A Report From the Los Angeles Cancer Surveillance Program

HER2 Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical Trials

Phase II California Cancer Consortium Trial of Gemcitabine-Eribulin Combination in Cisplatin-Ineligible Patients With Metastatic Urothelial Carcinoma: Final Report (NCI-9653)

Temozolomide for treatment-resistant recurrent meningioma

Early ductal decompression versus conservative management for gallstone pancreatitis with ampullary obstruction : A prospective randomized clinical trial

Carditis: a manifestation of gastroesophageal reflux disease

560 COMBINATION OF MOLECULAR ALTERATIONS AND SMOKING INTENSITY PREDICTS BLADDER CANCER OUTCOME: A REPORT FROM THE LOS ANGELES CANCER SURVEILLANCE PROGRAM

Phase I clinical trial of pegylated liposomal Doxorubicin and docetaxel in patients with advanced solid tumors

Telomerase and markers of cellular proliferation are associated with the progression of cervical intraepithelial neoplasia lesions

EphrinB2 (B2) expression predicts poor response to PD1/L1 antibodies (Ab) in metastatic urothelial carcinoma (mUC)

A phase 1 dose escalation/expansion study of FID-007, a novel nanoparticle paclitaxel formulation, in patients with solid tumors

Changes in ctDNA levels after MIBG therapy in patients with relapsed or refractory neuroblastoma

Phase II randomized double blind trial of axitinib (Axi) +/- PF-04518600, an OX40 antibody (PFOX) after PD1/PDL1 antibody (IO) therapy (Tx) in metastatic renal cell carcinoma (mRCC)

Neoplastic meningitis-related encephalopathy: prognostic significance

Group psychotherapy for women molested in childhood : Psychological and somatic symptoms and medical visits

Aktive Filter

Suchergebnisse filtern